Chamomile Infusion Reduces Ovarian Weight and Abdominal Vascular Permeability in a Rat Model of Ovarian Hyperstimulation Syndrome

Document Type : Original Research

Authors
M. E. Rezvani 1
M. Izadi 2
1 Yazd Neuroendocrine Research Center, School of Medicine, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran
2 Department of Reproductive Biology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Abstract
Introduction: The process by which new blood vessels are formed from pre-existing vessels is called angiogenesis. Regarding chamomile (Matricaria chamomilla, MC) contains anti-angiogenesis properties, Herein; the effect of MC infusion on ovarian hyperstimulation syndrome (OHSS) was evaluated using an experimental model of OHSS.

Methods: The sample (10 g) of the shade dried plant material was added to 1000 mL of boiling distilled water. This infusion kept for 10 min, then filtered and dried. OHSS was induced through the intra-peritoneal injection of pregnant mare serum gonadotropin (PMSG) and hCG. Treated groups were administered with 25 mg/kg of MC extract. Body and ovary weights were measured. Vascular permeability (VP) was determined through the injection of 2 mL of 5 mM Evans Blue and staining was quantified at 600 nm using a spectrophotometry.

Result: body weight gain observed in control OHSS group were attenuated by MC extract application (P<0.05). Also, MC decreased the ovarian weight and diameter in OHSS group. Vascular permeability was significantly decreased in MC treated rat in compared to control OHSS rats (P<0.05).

Conclusion: the results of the present study in a rat model indicate that MC infusion can reduce the severity of OHSS complications by reducing vascular permeability and protein leakage.

Keywords

Subjects

1- Alper M. M., Smith L. P., and Sills E. S., Ovarian hyperstimulation syndrome: current views on pathophysiology, risk factors, prevention, and management, Journal of Experimental and Clinical Assisted Reproduction. (2009) 6, article 3, 2-s2.0-77956378252.
2- Alper M. M., Smith L. P., and Sills E. S., Ovarian hyperstimulation syndrome: current views on pathophysiology, risk factors, prevention, and management, Journal of Experimental and Clinical Assisted Reproduction. (2009) 6, article 3, 2-s2.0-77956378252.
3- Budev M. M., Arroliga A. C., and Falcone T., Ovarian hyperstimulation syndrome, Critical Care Medicine. (2005) 33, no. 10, S301–S306,
4- Budev M. M., Arroliga A. C., and Falcone T., Ovarian hyperstimulation syndrome, Critical Care Medicine. (2005) 33, no. 10, S301–S306,
5- Asch R. H., Li H.-P., Balmaceda J. P., Weckstein L. N., and Stone S. C., Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups, Human Reproduction. (1991) 6, no. 10, 1395–1399, 2-s2.0-0026320642.
6- Hortu, Ismet, et al. "Oxytocin and cabergoline alleviate ovarian hyperstimulation syndrome (OHSS) by suppressing vascular endothelial growth factor (VEGF) in an experimental model." Archives of Gynecology and Obstetrics 303 (2021): 1099-1108.
7- Zhang, Jie, et al. "Ginkgo biloba extract 761 reduces vascular permeability of the ovary and improves the symptom of ovarian hyperstimulation syndrome in a rat model." Gynecological Endocrinology 38.4 (2022): 318-323.
8- Aboulghar, M.A. and Mansour, R.T. (2003) Ovarian Hyperstimulation Syndrome: Classifications and Critical Analysis of Preventive Measures. Human Reproduction Update, 9, 275-289.
9- Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update. 2002 Nov-Dec;8(6):559-77. doi: 10.1093/humupd/8.6.559. PMID: 12498425.R. Guimarães, L. Barros, M. Dueñas, R. C. Calhelha, A. M. Carvalho, C. Santos-Buelga, M. J. R. P. Queiroz and I. C. F. R. Ferreira, Food Chem., 2013, 136, 718–725
10- El-Assri, E.-M.; Eloutassi, N.; El Barnossi, A.; Bakkari, F.; Hmamou, A.; Bouia, A. Wild chamomile (Matricaria recutita L) from the Taounate Province, Morocco: Extraction and valorisation of the antibacterial activity of its essential oils. Trop. J. Nat. Prod. Res. 2021, 5, 883–888
11- Guimarães, Rafaela, et al. "Wild Roman chamomile extracts and phenolic compounds: enzymatic assays and molecular modelling studies with VEGFR-2 tyrosine kinase." Food & function 7.1 (2016): 79-83.
Pathobiology Reserach
Volume 26, Issue 1
November 2023
Pages 25-28